[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @Sanctuary_Bio WC WC posts on X about $srpt, esp, approved, twitter the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours. ### Engagements: XXXXX [#](/creator/twitter::849093025884237825/interactions)  - X Week XXXXXX -XX% - X Month XXXXXXX +17% - X Months XXXXXXX +41% - X Year XXXXXXX +53% ### Mentions: XX [#](/creator/twitter::849093025884237825/posts_active)  - X Months XXX +15% - X Year XXX +71% ### Followers: XXXXX [#](/creator/twitter::849093025884237825/followers)  - X Week XXXXX +1.50% - X Month XXXXX +2.70% - X Months XXXXX +7.50% - X Year XXXXX +13% ### CreatorRank: XXXXXXX [#](/creator/twitter::849093025884237825/influencer_rank)  ### Social Influence [#](/creator/twitter::849093025884237825/influence) --- **Social category influence** [stocks](/list/stocks) [finance](/list/finance) [social networks](/list/social-networks) [technology brands](/list/technology-brands) **Social topic influence** [$srpt](/topic/$srpt), [esp](/topic/esp), [approved](/topic/approved), [twitter](/topic/twitter), [$10b](/topic/$10b), [$108b](/topic/$108b), [$115b](/topic/$115b), [$mrk](/topic/$mrk), [$2b](/topic/$2b), [wegovy](/topic/wegovy) **Top assets mentioned** [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Hundred Million (100M)](/topic/$100m) ### Top Social Posts [#](/creator/twitter::849093025884237825/posts) --- Top posts by engagements in the last XX hours "XLRN 9/30/21 $11.5B RXDX 6/16/23 $10.8B VRNA 7/9/25 $10B The fact of the matter is $MRK has been the most prominent BP in the last few years in the $10B+ acq space. No one else is doing 10B+ deals every couple years"  [@Sanctuary_Bio](/creator/x/Sanctuary_Bio) on [X](/post/tweet/1942982970438287449) 2025-07-09 16:23:33 UTC 8905 followers, 15.5K engagements "@TOWiU2 *voluntarily pulled non-ambulatory"  [@Sanctuary_Bio](/creator/x/Sanctuary_Bio) on [X](/post/tweet/1945532860930429023) 2025-07-16 17:15:54 UTC 8904 followers, XXX engagements "@Vulpescap @MelvinRiskMgmt fwiw it's not just layoffs also updated discussions w/ FDA and pipeline prioritization. Even if you were certain layoffs would be PR'ed no guarantee on the other two esp in such a short time-frame"  [@Sanctuary_Bio](/creator/x/Sanctuary_Bio) on [X](/post/tweet/1945598653806383375) 2025-07-16 21:37:21 UTC 8904 followers, XXX engagements "@CoNaMaio @Soeren_Berlin @RNAiAnalyst the fact that it wasn't approved or phase X is irrelevant. You still disclose it even if it isn't in late stage development. Just like Pfizer did back in 2021 just like Neurogene did in November last year. Where are the relevant filings from Sarepta"  [@Sanctuary_Bio](/creator/x/Sanctuary_Bio) on [X](/post/tweet/1946576225964843066) 2025-07-19 14:21:52 UTC 8910 followers, XXX engagements "$SRPT Even though layoffs aren't exactly unexpected the upsetting part is that a lot of this could have been avoided if mgmt played their cards better. The patient death logistic issues ARWR deal.these are all on mgmt when are they losing their jobs"  [@Sanctuary_Bio](/creator/x/Sanctuary_Bio) on [X](/post/tweet/1945510030083793296) 2025-07-16 15:45:11 UTC 8910 followers, 9444 engagements "Appropriate that INSM data came this morning because this was the first name that came to my mind for a 'winner' Went public at 14/share 32M SO in 2000 Now 88/share 182M SO (after 10:1 RS) Investors back in 2000 still underwater. Valuation has 35x since then"  [@Sanctuary_Bio](/creator/x/Sanctuary_Bio) on [X](/post/tweet/1932424491352920217) 2025-06-10 13:07:56 UTC 8894 followers, 4867 engagements "@BenFranksAltEgo sure. Also another point which I don't think is major but worth mentioning Zepbound isn't approved for pediatrics. Wegovy can be used 12+ on-label but is less potent"  [@Sanctuary_Bio](/creator/x/Sanctuary_Bio) on [X](/post/tweet/1943329947172458915) 2025-07-10 15:22:19 UTC 8886 followers, XXX engagements "anyways hopefully those affected here will be able to find meaningful employment. Tough market these days"  [@Sanctuary_Bio](/creator/x/Sanctuary_Bio) on [X](/post/tweet/1945510197709136176) 2025-07-16 15:45:51 UTC 8907 followers, 1026 engagements "@JacobPlieth @ApexOnco I can't help but wonder if investors are frustrated by mgmt here. COGT has had a nice run but this could have been 2-3x if safety/efficacy at lower doses was fleshed out It feels like a case of where not spending $100M might easily cost you hundred of M or more in the long run"  [@Sanctuary_Bio](/creator/x/Sanctuary_Bio) on [X](/post/tweet/1942295068561531207) 2025-07-07 18:50:05 UTC 8905 followers, XXX engagements "@adamfeuerstein Fwiw isn't this breaking news Wouldn't expect pr from even a reputable company so soon esp fri after market close"  [@Sanctuary_Bio](/creator/x/Sanctuary_Bio) on [X](/post/tweet/1946353392437334356) 2025-07-18 23:36:24 UTC 8910 followers, 1306 engagements "$COGT while people debate commercial significance of bezu in iSM (and honestly I don't think that will be settled one way or another anytime soon) I think there will be some looks at the PEAK trial due eoy This one is pretty interesting. bezu+sunitinib vs sunitinib in 2l gist"  [@Sanctuary_Bio](/creator/x/Sanctuary_Bio) on [X](/post/tweet/1942647757459841077) 2025-07-08 18:11:32 UTC 8906 followers, 3108 engagements "$SRPT Posting for the benefit of those not following STAT+ or following @Biohazard3737 .everyone should be able to see this"  [@Sanctuary_Bio](/creator/x/Sanctuary_Bio) on [X](/post/tweet/1818028065722876223) 2024-07-29 20:57:22 UTC 8907 followers, 102.9K engagements "@drsprs which deals in particular during Biden era are you thinking of w/ large spreads I can remember ARNA in particular was large but all the other large acq I can remember were low single digit %.nothing worth chasing"  [@Sanctuary_Bio](/creator/x/Sanctuary_Bio) on [X](/post/tweet/1942959314504909129) 2025-07-09 14:49:33 UTC 8892 followers, XXX engagements "@yachmod No im just paraphrasing what he probably thought. Probably not far off Patient died of ALF"  [@Sanctuary_Bio](/creator/x/Sanctuary_Bio) on [X](/post/tweet/1946050037404106905) 2025-07-18 03:30:59 UTC 8907 followers, XXX engagements "@BiotechObserver that said REPL will be the real first test for Prasad. This is a single-arm combo study that by conventional thinking should justify AA. If it gets CRL watch out. No one is sweating over the CAPR CRL yet (except for longs I guess)"  [@Sanctuary_Bio](/creator/x/Sanctuary_Bio) on [X](/post/tweet/1943650519899378147) 2025-07-11 12:36:09 UTC 8909 followers, 9582 engagements "@AppleHelix @stockblues @A_May_MD @Sports_bios @AndyBiotech I don't have strong thoughts wrt nktr potential bd but history has shown repeatedly that bp bd is fallible. They make some good acq. And some very bad ones"  [@Sanctuary_Bio](/creator/x/Sanctuary_Bio) on [X](/post/tweet/1941945057827066326) 2025-07-06 19:39:16 UTC 8892 followers, 1064 engagements "$SRPT +57% in AH.guess we are using reddit for DD from now on $513M in 2Q isn't great.logistical challenges have a way to go Bb in non-ambulatory I doubt will change much.not a lot were being treated prior to deaths anyway still avoids worst-case scenario"  [@Sanctuary_Bio](/creator/x/Sanctuary_Bio) on [X](/post/tweet/1945577963829039585) 2025-07-16 20:15:08 UTC 8906 followers, 6762 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Sanctuary_Bio WC
WC posts on X about $srpt, esp, approved, twitter the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.
Engagements: XXXXX #
- X Week XXXXXX -XX%
- X Month XXXXXXX +17%
- X Months XXXXXXX +41%
- X Year XXXXXXX +53%
Mentions: XX #
- X Months XXX +15%
- X Year XXX +71%
Followers: XXXXX #
- X Week XXXXX +1.50%
- X Month XXXXX +2.70%
- X Months XXXXX +7.50%
- X Year XXXXX +13%
CreatorRank: XXXXXXX #
Social Influence #
Social category influence stocks finance social networks technology brands
Social topic influence $srpt, esp, approved, twitter, $10b, $108b, $115b, $mrk, $2b, wegovy
Top assets mentioned Sarepta Therapeutics, Inc. (SRPT) Merck & Co., Inc. (MRK) Hundred Million (100M)
Top Social Posts #
Top posts by engagements in the last XX hours
"XLRN 9/30/21 $11.5B RXDX 6/16/23 $10.8B VRNA 7/9/25 $10B The fact of the matter is $MRK has been the most prominent BP in the last few years in the $10B+ acq space. No one else is doing 10B+ deals every couple years"
@Sanctuary_Bio on X 2025-07-09 16:23:33 UTC 8905 followers, 15.5K engagements
"@TOWiU2 *voluntarily pulled non-ambulatory" @Sanctuary_Bio on X 2025-07-16 17:15:54 UTC 8904 followers, XXX engagements
"@Vulpescap @MelvinRiskMgmt fwiw it's not just layoffs also updated discussions w/ FDA and pipeline prioritization. Even if you were certain layoffs would be PR'ed no guarantee on the other two esp in such a short time-frame" @Sanctuary_Bio on X 2025-07-16 21:37:21 UTC 8904 followers, XXX engagements
"@CoNaMaio @Soeren_Berlin @RNAiAnalyst the fact that it wasn't approved or phase X is irrelevant. You still disclose it even if it isn't in late stage development. Just like Pfizer did back in 2021 just like Neurogene did in November last year. Where are the relevant filings from Sarepta" @Sanctuary_Bio on X 2025-07-19 14:21:52 UTC 8910 followers, XXX engagements
"$SRPT Even though layoffs aren't exactly unexpected the upsetting part is that a lot of this could have been avoided if mgmt played their cards better. The patient death logistic issues ARWR deal.these are all on mgmt when are they losing their jobs" @Sanctuary_Bio on X 2025-07-16 15:45:11 UTC 8910 followers, 9444 engagements
"Appropriate that INSM data came this morning because this was the first name that came to my mind for a 'winner' Went public at 14/share 32M SO in 2000 Now 88/share 182M SO (after 10:1 RS) Investors back in 2000 still underwater. Valuation has 35x since then" @Sanctuary_Bio on X 2025-06-10 13:07:56 UTC 8894 followers, 4867 engagements
"@BenFranksAltEgo sure. Also another point which I don't think is major but worth mentioning Zepbound isn't approved for pediatrics. Wegovy can be used 12+ on-label but is less potent" @Sanctuary_Bio on X 2025-07-10 15:22:19 UTC 8886 followers, XXX engagements
"anyways hopefully those affected here will be able to find meaningful employment. Tough market these days" @Sanctuary_Bio on X 2025-07-16 15:45:51 UTC 8907 followers, 1026 engagements
"@JacobPlieth @ApexOnco I can't help but wonder if investors are frustrated by mgmt here. COGT has had a nice run but this could have been 2-3x if safety/efficacy at lower doses was fleshed out It feels like a case of where not spending $100M might easily cost you hundred of M or more in the long run" @Sanctuary_Bio on X 2025-07-07 18:50:05 UTC 8905 followers, XXX engagements
"@adamfeuerstein Fwiw isn't this breaking news Wouldn't expect pr from even a reputable company so soon esp fri after market close" @Sanctuary_Bio on X 2025-07-18 23:36:24 UTC 8910 followers, 1306 engagements
"$COGT while people debate commercial significance of bezu in iSM (and honestly I don't think that will be settled one way or another anytime soon) I think there will be some looks at the PEAK trial due eoy This one is pretty interesting. bezu+sunitinib vs sunitinib in 2l gist" @Sanctuary_Bio on X 2025-07-08 18:11:32 UTC 8906 followers, 3108 engagements
"$SRPT Posting for the benefit of those not following STAT+ or following @Biohazard3737 .everyone should be able to see this" @Sanctuary_Bio on X 2024-07-29 20:57:22 UTC 8907 followers, 102.9K engagements
"@drsprs which deals in particular during Biden era are you thinking of w/ large spreads I can remember ARNA in particular was large but all the other large acq I can remember were low single digit %.nothing worth chasing" @Sanctuary_Bio on X 2025-07-09 14:49:33 UTC 8892 followers, XXX engagements
"@yachmod No im just paraphrasing what he probably thought. Probably not far off Patient died of ALF" @Sanctuary_Bio on X 2025-07-18 03:30:59 UTC 8907 followers, XXX engagements
"@BiotechObserver that said REPL will be the real first test for Prasad. This is a single-arm combo study that by conventional thinking should justify AA. If it gets CRL watch out. No one is sweating over the CAPR CRL yet (except for longs I guess)" @Sanctuary_Bio on X 2025-07-11 12:36:09 UTC 8909 followers, 9582 engagements
"@AppleHelix @stockblues @A_May_MD @Sports_bios @AndyBiotech I don't have strong thoughts wrt nktr potential bd but history has shown repeatedly that bp bd is fallible. They make some good acq. And some very bad ones" @Sanctuary_Bio on X 2025-07-06 19:39:16 UTC 8892 followers, 1064 engagements
"$SRPT +57% in AH.guess we are using reddit for DD from now on $513M in 2Q isn't great.logistical challenges have a way to go Bb in non-ambulatory I doubt will change much.not a lot were being treated prior to deaths anyway still avoids worst-case scenario" @Sanctuary_Bio on X 2025-07-16 20:15:08 UTC 8906 followers, 6762 engagements